All In MedTech

Device Trial Radar · NCT06636539

Prospective Case Collection Study of Contrast-Enhanced Mammography Imaging Acquired on a New Investigational Device

Last checked: Nov 20, 2026Latest source record: Jun 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

75

Planned (sponsor's estimate)

Start

Oct 14, 2024

Primary completion

Nov 5, 2026

Study completion Nov 5, 2026

Sponsor

Lead sponsor
Hologic, Inc.Public (HOLX)
Sponsor type
Industry
First posted
Oct 10, 2024

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Screening
FDA-regulated device
Yes
Who can join
Female only, from 35 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a prospective, multi-center image case collection study to acquire de-identified contrast-enhanced breast images on a mammography device to support continuing software technology development. Eligible subjects include women at least 35 years old with a suspicious finding or breast abnormality on a screening or diagnostic mammogram who are indicated for a diagnostic exam or a biopsy procedure.

Conditions

  • Breast Screening

Interventions

  • CEM Software in New Mammography DeviceDevice

    All subjects enrolled in the study will undergo a CEM exam.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of subjects (cases) with lesionsTime frame: 18 months

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • Solis Mammography Memorial Village

    Houston, Texas

  • Washington Radiology Sterling

    Sterling, Virginia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.